Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.5 USD | +0.45% | -2.73% | -19.52% |
02:35pm | Redburn Atlantic Adjusts Price Target on Gilead Sciences to $117 From $120 | MT |
29/04 | Barclays Adjusts Price Target on Gilead Sciences to $76 From $80 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.52% | 81.3B | |
+34.00% | 704B | |
+27.63% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+14.98% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead's Trodelvy 'Significantly Improves' Overall Survival in Pre-Treated Metastatic Breast Cancer Patients